MedMira Inc. (TSXV:MIR)

MedMira Income Statement

Financials in millions CAD. Fiscal year is August - July.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 31, 2025	Jul 31, 2024	Jul 31, 2023	Jul 31, 2022	Jul 31, 2021
Revenue	0.24	0.41	0.43	0.95	2.14
Revenue Growth (YoY)	-41.70%	-4.61%	-54.57%	-55.60%	133.33%
Cost of Revenue	0.91	1.03	0.87	1.46	1.43
Gross Profit	-0.67	-0.62	-0.43	-0.51	0.71
Selling, General & Admin	1.61	1.48	1.04	0.75	0.53
Research & Development	1.31	0.48	0.47	0.19	0.36
Operating Expenses	2.92	1.96	1.51	0.94	0.89
Operating Income	-3.59	-2.57	-1.94	-1.45	-0.18
Interest Expense	-1.08	-0.88	-0.89	-0.55	-0.65
Other Non Operating Income (Expenses)	0.14	0.13	0.15	0.17	0.16
Pretax Income	-4.52	-3.33	-2.68	-1.83	-0.68
Net Income	-4.52	-3.33	-2.68	-1.83	-0.68
Net Income to Common	-4.52	-3.33	-2.68	-1.83	-0.68
Shares Outstanding (Basic)	754	700	697	697	658
Shares Outstanding (Diluted)	754	700	697	697	658
Shares Change (YoY)	7.74%	0.35%	-	5.94%	-0.01%
EPS (Basic)	-0.01	-0.00	-0.00	-0.00	-0.00
EPS (Diluted)	-0.01	-0.00	-0.00	-0.00	-0.00
Free Cash Flow	-3.15	-3.68	-1.27	-1.95	-0.54
Free Cash Flow Per Share	-0.00	-0.01	-0.00	-0.00	-0.00
Gross Margin	-279.70%	-149.46%	-100.55%	-53.83%	33.11%
Operating Margin	-1492.56%	-623.65%	-449.52%	-152.63%	-8.59%
Profit Margin	-1881.18%	-806.25%	-618.61%	-192.37%	-31.51%
Free Cash Flow Margin	-1310.94%	-892.23%	-293.39%	-205.19%	-25.24%
EBITDA	-3.27	-2.53	-1.91	-1.42	-0.16
EBITDA Margin	-	-	-	-149.61%	-7.46%
D&A For EBITDA	0.32	0.04	0.03	0.03	0.02
EBIT	-3.59	-2.57	-1.94	-1.45	-0.18
EBIT Margin	-	-	-	-152.63%	-8.59%

Updated Jul 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.